Sign In
Buy VTRS
$17.56
-0.200 (-1.13%)
At Close: Jul 31, 2026
Viatris (VTRS) Reports Q3 Earnings: What Key Metrics Have to Say
10:32am, Thursday, 06'th Nov 2025
The headline numbers for Viatris (VTRS) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street esti
Viatris (VTRS) Beats Q3 Earnings and Revenue Estimates
09:15am, Thursday, 06'th Nov 2025
Viatris (VTRS) came out with quarterly earnings of $0.67 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.75 per share a year ago.
Viagra-maker Viatris beats quarterly estimates on strong demand for branded drugs
08:16am, Thursday, 06'th Nov 2025
Drugmaker Viatris beat third-quarter estimates for profit and revenue on Thursday, driven by strong demand for its branded drugs in China and emerging markets.
Viatris Inc (VTRS) Q3 2025 Earnings: EPS of $0.67 Beats Estimate, Revenue Surpasses Forecast at $3.76 Billion
08:11am, Thursday, 06'th Nov 2025
Revenue: Achieved $3.76 billion in Q3 2025, surpassing the estimated $3.61 billion.Earnings Per Share (EPS): Reported an adjusted EPS of $0.67, exceeding the e
Viatris Reports Third Quarter 2025 Results and Updates 2025 Financial Guidance
06:59am, Thursday, 06'th Nov 2025
Delivers Total Revenues in Line With Expectations, Reflecting Strong Execution of its Global Business Makes Late-Stage Pipeline Progress Including NDA Submission for Low-Dose Estrogen Weekly Patch Acq
Countdown to Viatris (VTRS) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
10:15am, Wednesday, 05'th Nov 2025
Evaluate the expected performance of Viatris (VTRS) for the quarter ended September 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metric
Viatris Announces Quarterly Dividend
06:59am, Tuesday, 04'th Nov 2025
PITTSBURGH , Nov. 4, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that on November 3, 2025, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued
Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?
11:06am, Thursday, 30'th Oct 2025
Viatris (VTRS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Viatris (VTRS) Stock Undervalued Right Now?
10:41am, Tuesday, 28'th Oct 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Will Viatris (VTRS) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Tuesday, 21'st Oct 2025
Viatris (VTRS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Teva Vs. Viatris: Who Will Dominate In President Trump's America?
12:18pm, Friday, 17'th Oct 2025
Teva Pharmaceuticals and Viatris occupy leading positions in the generic drugs market, valued at more than $613 billion in 2030. Each of them has advantages and "dark spots" in their portfolios of FDA
Viatris Acquires Aculys Pharma to Expand Neurology Portfolio in Japan
12:16pm, Thursday, 16'th Oct 2025
VTRS acquires Aculys Pharma to boost its CNS portfolio in Japan, gaining rights to pitolisant and Spydia for narcolepsy and seizure management, respectively.
Strengthens Viatris' Presence in Japan With the Addition of Two Innovative Assets Targeting Areas of Significant Unmet Medical Need Leverages Existing Infrastructure and Expertise in Central Nervous S
Viatris to Participate in Upcoming Investor Conferences
06:59am, Monday, 13'th Oct 2025
PITTSBURGH , Oct. 13, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the Company will participate in two upcoming healthcare conferences in Novembe
Viatris Named to Forbes' Annual List of the World's Best Employers for the Fifth Year in a Row
11:00am, Wednesday, 08'th Oct 2025
PITTSBURGH , Oct. 8, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that it has been named to Forbes' list of World's Best Employers 2025. This is the
